Navigation Links
AvMed Covers H1N1 Flu Vaccine For Members
Date:10/12/2009

MIAMI, Oct. 12 /PRNewswire/ -- AvMed Health Plans announced that it will cover H1N1 flu administration fees for all of its fully insured members. Co-pays, co-insurance and deductibles will not apply for administration of the H1N1 vaccine even if they have a benefit plan that does not include immunizations.

"AvMed is committed to the health and well-being of our members and we want to ensure that the H1N1 national emergency vaccination effort goes as smoothly as possible," said Kirk Cianciolo, D.O., Senior Vice President and Chief Medical Officer of AvMed Health Plans.

Additionally, AvMed is providing members and employers educational materials related to H1N1 virus, including the following current guidelines and information from the Centers for Disease Control and Prevention (CDC):

The CDC is recommending that programs and providers administer the vaccine to persons in the following five target groups (order of target groups does not indicate priority):

  • Pregnant women,
  • Persons who live with or provide care for infants aged <6 months (e.g., parents, siblings, and daycare providers),
  • Health care and emergency medical services personnel,
  • Persons aged 6 months through 24 years, and
  • Persons aged 25 through 64 years who have medical conditions that put them at higher risk for influenza-related complications.

AvMed is closely monitoring the developments related to the H1N1 flu vaccine. For more information, log on to www.avmed.org or www.cdc.gov/h1n1flu.

About AvMed Health Plans

With more than 35 years in Florida, AvMed is one of the state's oldest and largest not-for-profit health plans, and is solely focused on providing health coverage to Florida citizens and businesses. AvMed is one of only a few health plans in the United States that enjoys dual "Excellent" accreditation status for both its commercial and Medicare health plans from the National Committee for Quality Assurance, the nation's top health care quality evaluator. In addition, AvMed has received an "A," or "Excellent" rating by TheStreet.com Ratings, placing it among the top six percent of all health plans in the United States in terms of financial strength.

SOURCE AvMed Health Plans


'/>"/>
SOURCE AvMed Health Plans
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
2. Video: New Research Discovers Independent Brain Networks Control Human Walking
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
7. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
8. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
9. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
10. American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks
11. The Childrens Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohns Disease Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Dec. 5, 2016  CVS Health, the nation,s largest ... a perfect score of 100 percent on the Corporate ... CEI is an annual national benchmarking survey and report ... administered by the Human Rights Campaign Foundation. ... that our colleagues, customers and suppliers bring to CVS ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... founder of Spectrum Science Communications , announced today that ... two consecutive years of high double digit growth in fee revenues. ... assumed management of the firm that Seng founded in 1996. Earlier ... of the Year and was selected among the Best Places to ... ...
Breaking Medicine Technology:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... and characterization laboratories, is now offering HIAC particle counting and sizing services for ... , Gateway Analytical instituted the new service as a response to the needs ...
(Date:12/6/2016)... CA (PRWEB) , ... December 06, 2016 , ... 'Tis ... can disrupt daily routines. That means it's also the season when eating healthy, staying ... living with diabetes) on schedule is harder to do. , "Shopping trips, parties ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has announced the ... providing occupational safety and health training to public sector employees. , “The primary ...
(Date:12/5/2016)... ... December 05, 2016 , ... Edward Buckingham MD , ... arrival of the newest Sciton laser in January 2017. The Halo is the ... and ablative wavelengths for exceptional results. Outperforming more traditional lasers, the innovative Halo ...
(Date:12/5/2016)... ... , ... Researchers at Johns Hopkins All Children’s Hospital want to learn more ... course of three years, researchers will study concussions and changes in brain function by ... special sensors, will track the location and force of the hit. The sensors store ...
Breaking Medicine News(10 mins):